alterlab-glycoengineering

To predict glycosylation sites, provide a protein sequence to identify canonical N-glycosylation sequons (N-X-[S/T], X ≠ P) and flag Ser/Thr-rich O-glycosylation hotspots, yielding site-level mapped results.

Yes, glycoengineering supports antibody optimization and therapeutic protein design by analyzing glycosylation patterns to guide modifications that improve protein stability, pharmacokinetics, and immunogenicity.

O-glycosylation hotspot prediction works by scanning protein sequences for Ser/Thr-rich regions likely to bear O-glycans, flagging these areas for further validation with external prediction tools.

Yes, the glycoengineering analysis integrates with curated tools including NetOGlyc, GlycoShield, and GlycoWorkbench, providing access to external databases for extended predictions and exploratory analysis.

You need to provide a protein sequence to analyze N- and O-glycosylation sites. The solution processes the sequence to return site-level details and suggested external resources for further validation.

You should validate glycoengineering predictions with external databases when proceeding to vaccine antigen design or therapeutic development, as sequence-based analysis provides initial site mapping that requires confirmatory exploratory analysis.